CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

An auto-questionnaire comprising three psychometric scalesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D011248 Pregnancy Complications NIH 0.41

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns

The purpose of this study is to characterize the incidence and clinical features of the maternal COVID 19 infection, as well as the associated morbidity of the mother and the child, in the French context

NCT04463758 covid19 In covid19 Infection Pregnancy Complications Neonatal Complications Other: An auto-questionnaire comprising three psychometric scales
MeSH:Pregnancy Complications

Primary Outcomes

Description: Maternal Criterion: Validated Composite Criterion of Severe Maternal Morbidity (Epimoms study ref 7). Neonatal Criterion: Mortality and Composite Criterion of Severe Neonatal Morbidity Perinatal asphyxia (arterial pH to cord-7.15 and/or an excess base - 10mmol/L and/or lactates-6 mmol/L, Apgar score at 5 minutes -7), neonatal encephalopathy, seizures, intraventricular hemorrhage, cerebral infarction, periventricular leucomalacia, ulcerative enterocolite, sepsis, respiratory distress syndrome, bronchopulmonary dysplasia, central catheter, ventilatory support, transfusion

Measure: Joint evaluation of morbi-mortality for mother and child up to 12 weeks postpartum

Time: At12 weeks after delivery

Secondary Outcomes

Measure: Number of women infection COVID-19

Time: During pregnancy and up to 12 weeks

Measure: Severe forms of COVID-19 infection in the mother

Time: Until 12 weeks after delivery

Measure: Severe neonatal morbidity

Time: Until 12 weeks after delivery

No related HPO nodes (Using clinical trials)